Skip to main content

Exit WCAG Theme

Switch to Non-ADA Website

Accessibility Options

Select Text Sizes

Select Text Color

Website Accessibility Information Close Options
Close Menu
Spencer Morgan Law, Spencer G. Morgan, Attorney At Law Miami Personal Injury Lawyer
  • Call Now 24/7 for a Free Consultation
  • ~
  • Firm Direct Text 786-353-0688
  • ~
  • No Fees or Costs If No Recovery
  • ~
  • Toll Free: 866-667-4265
  • ~
  • En Español

Miami Elmiron Lawyer

Elmiron (pentosan polysulfate sodium) is prescribed to treat bladder pain caused by interstitial cystitis (IC). Many patients who suffer from IC experience chronic bladder pain and pressure, and they understandably want relief. Elmiron is the only drug available to treat IC bladder pain, but scientists do not even fully understand how it works. It is believed to stop bladder pain by creating a protective barrier on the bladder wall to stop irritants in urine from resulting in bladder inflammation. The serious downside to taking Elmiron is that it may cause pigmentary maculopathy, according to Drug Watch. If you have suffered any sight loss, including blurred vision or trouble seeing in low light settings, since you began taking Elmiron, you may be able to file a lawsuit against the manufacturer, Janssen Pharmaceuticals, for failing to warn you about the potential vision damage that their drug causes. The Miami Elmiron lawyers at Spencer Morgan Law can help you throughout this process, and will ensure that your best interests are carried out during the legal process.

Studies Involving Elmiron

According to, a 2018 study was published in Ophthalmology that documented six cases of possibly avoidable maculopathy that was linked to taking Elmiron. Further studies came to similar conclusions. As a result, in 2019 the manufacturer Jassen Pharmaceuticals put a warning about pigmentary maculopathy with chronic use on Canadian labels. However, they failed to notify American consumers until June 2020. Despite these studies, there has been no push from The U.S Food and Drug Administration (FDA) to further investigate or recall Elmiron and Jassen Pharmaceuticals has not issued any voluntary recalls. 

Signs You May Have Vision Problems Associated with Elmiron

  • Blurred vision;
  • Distorted vision;
  • Pigmentary maculopathy;
  • Retinal maculopathy;
  • Macular degeneration;
  • Eye pain;
  • Trouble with reading;
  • Vision loss;
  • Visual disturbances;
  • Scotoma;
  • Reduced night vision; and
  • Halo vision.

Are You Eligible for Compensation?

In general, any person who has been taking Elmiron for two years or more and has experienced vision issues such as the ones listed above could be eligible to seek compensation. If you fall into this category, you should seek an ophthalmologist and contact a Elmiron attorney. Even if you have not been taking the drug for two years but notice worsening vision problems, it is worth exploring other possible medications and speaking with an attorney.

Call the Miami Elmiron Lawyers at Spencer Morgan Law

Victims of Elmiron eyesight injuries may be eligible to receive compensation for their lost earning capacity, pain and suffering, loss of quality of life, medical bills, eyesight treatment and vision impairment devices, and more. If you have noticed any signs of worsening vision, it is important to get to a doctor soon. Not only is medical treatment important to diagnose the cause of your eyesight damage, but it is important to document any changes in your vision in order for legal proof if you decide to file a lawsuit against the manufacturer of Elmiron. We strongly encourage you to call the Miami law offices of Spencer Morgan Law today at 305-423-3800 to discuss your next move.

Share This Page:

Please fill out the form provided and one of our dedicated staff members will assist you in scheduling a free consultation.

By submitting this form I acknowledge that form submissions via this website do not create an attorney-client relationship, and any information I send is not protected by attorney-client privilege.

Skip footer and go back to main navigation